Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFZ.L Regulatory News (PFZ)

  • There is currently no data for PFZ

Rule 8.1 - Pfizer INC

4 Nov 2015 11:33

RNS Number : 5265E
Morgan Stanley Cap. (Luxembourg) SA
04 November 2015
Β 

ο»Ώ

Β 

Β 

Β 

Β 

FORMΒ 8.1(a)&(b)(i)

Β 

IRISHΒ TAKEOVERΒ PANEL

Β 

DISCLOSUREΒ UNDERΒ RULEΒ 8.1(a)Β ANDΒ (b)(i)Β OFΒ THEΒ IRISHΒ TAKEOVERΒ PANELΒ ACT,Β 1997,Β TAKEOVERΒ RULES,Β 2013

Β 

DEALINGSΒ BYΒ OFFERORS,Β OFFEREESΒ ORΒ PARTIES ACTINGΒ INΒ CONCERTΒ WITHΒ THEMΒ FORΒ THEMSELVESΒ ORΒ FORΒ DISCRETIONARYΒ CLIENTS

Β 

1. KEYΒ INFORMATION

Β 

Name of person dealing (Note 1)

Morgan Stanley Capital (Luxembourg) S.A.

Company dealt in

PFIZER INC

Class of relevant security to which the dealings being disclosed relate (Note 2)

US$0.05 COMMON STOCK

Date of dealing

02 NOVEMBER 2015

Β 

2. INTERESTSΒ ANDΒ SHORTΒ POSITIONS

Β 

(a) InterestsΒ andΒ shortΒ positionsΒ (followingΒ dealing)Β inΒ theΒ classΒ ofΒ relevantΒ securityΒ dealtΒ inΒ (NoteΒ 3)

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

124,969 0.00

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

124,969 0.00

Β 

(b) InterestsΒ andΒ shortΒ positionsΒ inΒ relevantΒ securitiesΒ ofΒ theΒ company,Β otherΒ thanΒ theΒ classΒ dealtΒ inΒ (NoteΒ 3)

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

N/A

N/A

Β 

(2) Derivatives (other than options)

N/A

N/A

Β 

(3) Options and agreements to purchase/sell

N/A

N/A

Total

N/A

N/A

Β 

Β 

3. DEALINGSΒ (NoteΒ 4)

Β 

(a) PurchasesΒ andΒ sales

Β 

Purchase/sale

Number of relevant securities

Price per unit (Note 5)

PURCHASE

8,862

33.8200 USD

Β 

Β 

(b) DerivativesΒ transactionsΒ (otherΒ thanΒ optionsΒ transactions)

Β 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

N/A

N/A

N/A

N/A

Β 

Β 

(c) OptionsΒ transactionsΒ inΒ respectΒ ofΒ existingΒ relevantΒ securities

Β 

Β 

(i) Writing,Β selling,Β purchasingΒ orΒ varying

Β 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Β 

Β 

(ii) Exercising

Β 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

N/A

N/A

N/A

Β 

Β 

(d) OtherΒ dealingsΒ (includingΒ transactionsΒ inΒ respectΒ ofΒ newΒ securities)Β (NoteΒ 4)

Β 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

N/A

N/A

N/A

Ap11

Β 

4. OTHERΒ INFORMATION

Β 

Agreements,Β arrangementsΒ orΒ understandingsΒ relatingΒ toΒ optionsΒ orΒ derivatives

Β 

Β 

Β 

Β 

FullΒ detailsΒ ofΒ anyΒ agreement,Β arrangementΒ orΒ understandingΒ betweenΒ theΒ personΒ disclosing andΒ anyΒ otherΒ personΒ relatingΒ toΒ theΒ votingΒ rightsΒ ofΒ anyΒ relevantΒ securitiesΒ underΒ anyΒ option referredΒ toΒ onΒ thisΒ formΒ orΒ relatingΒ toΒ theΒ votingΒ rightsΒ orΒ futureΒ acquisitionΒ orΒ disposalΒ ofΒ anyrelevantΒ securitiesΒ toΒ whichΒ anyΒ derivativeΒ referredΒ toΒ onΒ thisΒ formΒ isΒ referenced.

IfΒ none,Β this shouldΒ beΒ stated.

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

IsΒ aΒ SupplementalΒ FormΒ 8Β attached?Β (NoteΒ 9) Β NO

Β 

Date of disclosure

04 NOVEMBER 2015

Contact name

Craig Horsley

Telephone number

+44(141) 245 7736

Name of offeree/offeror with which acting in concert

ALLERGAN PLC

Specify category and nature of acting in concert status

Advisory

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ISEBIBBTMBTMBPA
Date   Source Headline
11th Nov 20153:04 pmRNSForm 8.3 - Pfizer Inc
11th Nov 20152:59 pmRNSForm 8.3 - Pfizer Inc Amendment
11th Nov 20152:44 pmRNSForm 8.3 - Allergan Plc
11th Nov 20151:45 pmRNSForm 8.1(a) - Pfizer Inc.
11th Nov 201512:45 pmRNSForm 8.3 - Allergan plc
11th Nov 201511:55 amRNSForm 8.3 - Pfizer Inc
11th Nov 201511:52 amRNSForm 38.5(b) - Pfizer Inc
11th Nov 201511:01 amRNSRule 38.5 - Pfizer INC
11th Nov 201510:47 amRNSForm 8.1 - [Pfizer Inc]
11th Nov 201510:44 amRNSForm 38.5b
11th Nov 201510:41 amRNSForm 38.5a
10th Nov 20155:19 pmRNSRule 38.5 - Replacement Pfizer INC
10th Nov 20153:29 pmRNSForm 8.3 - Pfizer Inc
10th Nov 20153:23 pmRNSForm 8.3 - Pfizer Inc
10th Nov 20153:16 pmRNSForm 8.3 - [PFIZER INC]
10th Nov 20153:12 pmRNSForm 8.3 - Allergan plc
10th Nov 20153:04 pmRNSForm 8.3 - Pfizer Inc
10th Nov 20152:54 pmRNSForm 8.3 - Pfizer, Inc.
10th Nov 20152:45 pmRNSForm 8.3 - Allergan Plc
10th Nov 20152:31 pmRNSForm 8.3 - ALLERGAN PLC
10th Nov 20152:28 pmRNSForm 8.3 - PFIZER INC
10th Nov 20152:12 pmBUSForm 8.3 - Pfizer Inc.
10th Nov 201512:35 pmRNSForm 38.5(b) - Pfizer Inc
10th Nov 201512:13 pmRNSForm 38.5b
10th Nov 201512:10 pmRNSForm 38.5b
10th Nov 201512:05 pmRNSForm 38.5a
10th Nov 201512:02 pmRNSForm 8.1 - [Pfizer Inc]
10th Nov 201511:55 amRNSForm 8.3 - Pfizer Inc.
10th Nov 201511:16 amRNSRule 38.5 - Pfizer INC
10th Nov 201511:11 amRNSRule 38.5 - Replacement Pfizer INC
10th Nov 201511:10 amRNSRule 38.5 - Replacement Pfizer INC
9th Nov 20154:30 pmRNSForm 8.3 - Allergan plc
9th Nov 20153:44 pmRNSForm 8.3 - PFIZER INC
9th Nov 20153:33 pmRNSForm 8.3 - Pfizer Inc
9th Nov 20153:25 pmRNSForm 8.3 - Pfizer Inc
9th Nov 20153:24 pmRNSForm 8.3 - Pfizer Inc Amendment
9th Nov 20153:16 pmRNSForm 8.3 - [PFIZER INC]
9th Nov 20152:58 pmRNSForm 8.3 - ALLERGAN PLC
9th Nov 20152:48 pmRNSForm 8.3 - Pfizer, Inc.
9th Nov 20152:37 pmRNSForm 8.3 - Pfizer Inc
9th Nov 20152:26 pmRNSForm 8.3 - Allergan Plc
9th Nov 201512:02 pmRNSForm 38.5b
9th Nov 201511:59 amRNSForm 38.5b
9th Nov 201511:56 amRNSForm 38.5a
9th Nov 201511:55 amRNSForm 8.1 - [Pfizer Inc]
9th Nov 201511:55 amRNSForm 8.3 - Pfizer Inc.
9th Nov 201511:41 amRNSForm 38.5(b) - Pfizer Inc.
9th Nov 201510:58 amRNSRule 38.5 - Pfizer INC
9th Nov 201510:56 amRNSRule 38.5 - Pfizer INC
6th Nov 20154:16 pmRNSRule 38.5 - Replacement Pfizer INC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.